Breast Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Breast Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Sep 13, 2018

---

• Are We Being Misled About Precision Medicine?  
  L Szabo, New York Times, September 11, 2018
• Future of Evidence Synthesis in Precision Oncology: Between Systematic Reviews and Biocuration  
  SM Boca et al, JCO Precision Oncology, September 2018
• High rate of occult cancer found in prophylactic mastectomy specimens despite thorough presurgical assessment with MRI and ultrasound: findings from the Hereditary Breast and Ovarian Cancer Registration 2016 in Japan.  
  Yamauchi Hideko et al. Breast cancer research and treatment 2018 Sep
• Incidence of Pathogenic Variants in Those With a Family History of Pancreatic Cancer.  
  Macklin Sarah K et al. Frontiers in oncology 2018 8330
• Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.  
  Buus Richard et al. Breast cancer research : BCR 2018 Sep 20(1) 103
• Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.  
  Dossa Fahima et al. BMJ open 2018 Sep 8(9) e025317
• Researchers can forecast risk of deadly vascular condition from genome sequence 
  Stanford Medicine, September 6, 2018
• A portrait of germline mutation in Brazilian at-risk for hereditary breast cancer.  
  de Souza Timoteo Ana Rafaela et al. Breast cancer research and treatment 2018 Aug
• Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.  
  Zhang Xuehong et al. PLoS medicine 2018 Sep 15(9) e1002644
• BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.  
  Gross Amy L et al. JAMA 2018 Aug 320(6) 597-598